image
BioCryst Pharmaceuticals, Inc. BCRX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 7.03
-5.64 %
$ 1.46 B
Market Cap
-11.92
P/E
INCOME STATEMENT
331 M REVENUE
22.37%
Growth Rates
1Year 22.37%
3Years 164.98%
5Years 74.21%
7Years 43.57%
10Years 34.32%
-104 M OPERATING INCOME
30.13%
Growth Rates
1Year 30.13%
3Years 15.96%
5Years -1.94%
7Years -11.43%
10Years -12.94%
-227 M NET INCOME
8.33%
Growth Rates
1Year 8.33%
3Years -7.41%
5Years -17.48%
7Years -22.37%
10Years -22.36%
EFFICIENCY
Earnings Waterfall BioCryst Pharmaceuticals, Inc.
image
Revenue 331 M
Cost Of Revenue 4.66 M
Gross Profit 327 M
Operating Expenses 431 M
Operating Income -104 M
Other Expenses 123 M
Net Income -227 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994
REVENUE
Revenue 331.4 270.8 157.2 17.8 48.8 20.7 25.2 26.4 48.3 13.6 17.3 26.3 19.6 63.5 74.6 56.6 71.2 6.2 0.2 0.3 1.6 1.8 11.2 3.3 2.5 6.4 1.0 2.7 0.2 0.7
GROSS PROFIT
Cost Of Revenue 4.7 6.6 7.3 1.7 4.1 0.5 1.7 2.7 1.9 0.1 98 K 0.1 0 86 K 4.5 0 0 0 0 0 0 0 0 0 (0.5) (0.5) (0.6) 7.1 6.5 5.0
Gross Profit 326.8 264.2 149.9 16.1 44.7 20.2 23.5 23.7 46.4 13.5 17.2 26.2 19.6 63.4 70.0 56.6 71.2 6.2 0.2 0.3 1.6 1.8 11.2 3.3 3.0 6.9 1.6 (4.4) (6.3) (4.3)
OPERATING INCOME
Operating Expenses 430.6 412.7 327.6 190.9 144.2 114.4 80.9 72.3 85.8 59.3 48.0 58.3 69.2 96.7 83.8 83.7 103.5 53.2 27.3 22.1 14.3 18.3 16.1 13.1 11.1 12.9 13.9 3.2 2.8 2.5
Selling, General and Administrative Expenses 213.9 159.4 118.8 67.9 37.1 29.5 13.9 11.3 13.0 7.5 5.2 6.8 12.3 14.2 11.5 10.4 9.5 6.1 3.7 3.2 2.8 2.9 3.1 3.6 2.9 3.1 2.7 2.7 2.2 1.9
Research and Development Expenses 216.6 253.3 208.8 123.0 107.1 84.9 67.0 61.0 72.8 51.8 42.7 51.5 56.9 82.5 72.3 73.3 94.1 47.1 23.6 18.9 11.5 15.5 13.1 9.6 7.7 9.3 10.6 0 0 0
Operating Income (103.7) (148.4) (177.7) (174.8) (99.5) (94.2) (57.4) (48.6) (39.4) (45.8) (30.7) (33.9) (49.6) (33.2) (13.7) (27.2) (32.3) (47.0) (27.2) (21.8) (12.7) (16.6) (5.0) (9.8) (8.1) (6.0) (12.3) (7.6) (9.1) (6.8)
PRE-TAX INCOME
Interest Income Expense 108.2 99.1 59.3 14.5 11.9 9.2 8.6 6.5 5.2 5.0 4.8 4.7 3.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Other Income (122.5) (95.9) (4.1) (8.1) (9.4) (7.0) (8.4) (6.5) (3.6) 0.6 0.6 (5.2) (7.4) 0.5 0.3 2.4 3.2 (26 051.8) 27.2 0.6 (12 686.4) 18.7 (4 981.0) (11 568.0) 1.2 1.3 1.7 0 0.7 0
Pre-Tax Income (226.2) (244.4) (181.8) (182.8) (108.9) (101.3) (65.8) (55.1) (43.0) (45.2) (30.1) (39.1) (56.9) (33 853.2) (13.5) (24.7) (29.1) (26 098.8) (26 098.8) (21 104.1) (12 700.1) (16 928.7) (4 986.0) (11 577.8) (6.9) (4.7) (10.6) 0 (8.4) 0
NET INCOME
Tax Provision 0.3 2.7 2.3 13.8 11.2 2.1 7.9 6.0 5.0 4.8 4.5 4.0 6.5 500.8 (1.6) 430 524 (26 055.2) 1 077.0 (0.6) (12 687.4) 0.4 (4 981.0) (11 566.3) (2.8) (1.2) (1.7) 100 K (0.5) 100 K
Net Income (226.5) (247.1) (184.1) (196.6) (120.1) (101.3) (65.8) (55.1) (43.0) (45.2) (30.1) (39.1) (56.9) (32.7) (13.5) (24.7) (29.1) (43.6) (26.1) (21.1) (12.7) (16.9) (5.0) (11.6) (5.3) (4.8) (10.6) (7.7) (8.6) (6.9)
EPS 1.18 1.33 1.03 1.18 1.04 0.98 0.78 0.75 0.59 0.68 0.55 0.79 1.26 0.73 0.35 0.65 0.89 1.5 1.01 1 0.72 0.96 0.28 0.66 0.34 0.34 0.77 0.69 0.96 1.02